Pharmacokinetic properties of isradipine after single-dose and multiple-dose oral administration in Chinese volunteers: a randomized, open-label, parallel-group phase I study-Reference-Cited by-同舟云学术

Pharmacokinetic properties of isradipine after single-dose and multiple-dose oral administration in Chinese volunteers: a randomized, open-label, parallel-group phase I study

Published:2013-07-01 Issue:12 Volume:27 Page:1664-1670
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomed. Chromatogr.

Author:

Wang Yanran¹,Jin Zhaohui²,Wang Zhijun³,Jiang Xuehua¹,Wang Ling¹

Affiliation:

1. West China School of Pharmacy, Sichuan University; Department of Clinical Pharmacy and Pharmacy Administration; Chengdu Sichuan China

2. West China Hospital of Sichuan University; Department of Pharmacy; Chengdu Sichuan China

3. Center for Advancement of Drug Research and Evaluation, College of Pharmacy; Western University of Health Sciences; Pomona CA 91766 USA

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference13 articles.

1. Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine;Anekonda;Biochimica et Biophysica Acta,2011

2. Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam;Backman;Clinical Pharmacology and Therapeutics,1999

3. Voltammetric determination of isradipine in dosage forms and spiked human plasma and urine;Belal;Journal of Pharmaceutical and Biomedical Analysis,2003

4. Bioavailability and pharmacokinetics of isradipine after oral and intravenous administration: half-life shorter than expected?;Christensen;Pharmacology & Toxicology,2000

5. Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease;Fitton;Drugs,1990

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. L-type calcium channel regulation of depression, anxiety and anhedonia-related behavioral phenotypes following chronic stress exposure;Neuropharmacology;2024-10

2. Novel protocol for multiple-dose oral administration of the L-type Ca ²⁺ channel blocker isradipine in mice: A dose-finding pharmacokinetic study;Channels;2024-04-02

3. CACNA1D-Related Channelopathies: From Hypertension to Autism;Voltage-gated Ca2+ Channels: Pharmacology, Modulation and their Role in Human Disease;2023

4. Isradipine plasma pharmacokinetics and exposure–response in early Parkinson’s disease;Annals of Clinical and Translational Neurology;2021-01-18

5. A COMPLETE GUIDE ON THE PHARMACOLOGIC AND PHARMACOTHERAPEUTIC ASPECTS OF CALCIUM CHANNEL BLOCKERS: AN EXTENSIVE REVIEW;INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH;2019-11-01